The pancreatic cancer survival rate continues to improve as research leads to new and better ways to diagnose and treat the condition. However, when discussing the survival rate, it’s important to remember that it is nothing more than a statistic. Every patient is unique and every cancer is different. A statistic can only describe what happened retrospectively in a very large group – it does not take into account the advances in cancer care that are being made every single day, nor can it predict the outcome in any individual situation. In fact, some patients live much longer than the amount of time that would be anticipated based on the survival rate alone.
Of course, a patient might be interested in learning as much as he or she can about the condition, including its pancreatic cancer survival rate. The following points hold true regarding the prognosis for pancreatic cancer:
- An early and accurate diagnosis and prompt, appropriate treatment can improve a patient’s outlook.
- Patients who undergo surgery tend to experience better outcomes than patients who are treated nonsurgically.
- All other things being equal, a newly diagnosed cancer patient can potentially experience a better outcome than a patient who was diagnosed several years ago due to recent scientific developments.
- Many individual factors can influence pancreatic cancer outcomes, such as a patient’s overall health and wellness.
Within Moffitt Cancer Center’s Gastrointestinal Oncology Program, our pancreatic cancer patients not only have access to some of the best surgeons in the country, but also benefit from the latest treatment options, a wide range of clinical trials and compassionate support, all of which are provided in a single, convenient location. Moffitt is the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, and we remain positioned firmly at the forefront of cancer research, with survival rates that exceed national averages.